These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6501238)

  • 1. Serum imipramine concentrations lower than plasma values.
    Hullett FJ; Levy AB; Tachiki KH
    J Clin Psychiatry; 1984 Dec; 45(12):516-8. PubMed ID: 6501238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time.
    Ziegler VE; Biggs JT; Rosen SH; Meyer DA; Preskorn SH
    J Clin Psychiatry; 1978 Aug; 39(8):660-3. PubMed ID: 681303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases.
    Devane CL; Wolin RE; Rovere RA; Panahon NC; Sutfin TA; Jusko WJ
    J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
    Szymura-Oleksiak J; Wasieczko A
    Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the route of administration of imipramine on imipramine and desipramine blood levels.
    Rigal J; Albin H; Fança X; Demotes-Mainard F; Vinçon G
    J Clin Psychopharmacol; 1989 Oct; 9(5):364-7. PubMed ID: 2677063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma tricyclic levels with therapeutic doses of imipramine.
    Garvey MJ; Tuason VB; Johnson RA; Valentine RH; Cooper TB
    Am J Psychiatry; 1984 Jul; 141(7):853-6. PubMed ID: 6731633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder.
    Mavissakalian MR; Perel JM
    Psychopharmacol Bull; 1996; 32(1):143-7. PubMed ID: 8927664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine.
    Simpson GM; White KL; Boyd JL; Cooper TB; Halaris A; Wilson IC; Raman EJ; Ruther E
    Am J Psychiatry; 1982 Mar; 139(3):358-60. PubMed ID: 7036761
    [No Abstract]   [Full Text] [Related]  

  • 13. Steady-state plasma imipramine levels in prepubertal depressed children.
    Weller EB; Weller RA; Preskorn SH; Glotzbach R
    Am J Psychiatry; 1982 Apr; 139(4):506-8. PubMed ID: 7065300
    [No Abstract]   [Full Text] [Related]  

  • 14. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of imipramine and clinical response among depressed outpatients.
    Matuzas W; Javaid JI; Glass R; Davis JM; Ross JA; Uhlenhuth EH
    J Clin Psychopharmacol; 1982 Apr; 2(2):140-2. PubMed ID: 7042772
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for in vivo methylation of the secondary amino antidepressant desipramine to imipramine in humans.
    Narasimhachari N; Saady JJ; Joseph A; Ettigi P; Friedel RO
    J Clin Psychopharmacol; 1982 Dec; 2(6):413-6. PubMed ID: 7174866
    [No Abstract]   [Full Text] [Related]  

  • 17. Imipramine and tinnitus.
    Tandon R; Grunhaus L; Greden JF
    J Clin Psychiatry; 1987 Mar; 48(3):109-11. PubMed ID: 3818550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
    Sutfin TA; Perini GI; Molnar G; Jusko WJ
    J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of therapeutic response to antidepressant plasma levels: an update.
    Friedel RO
    J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):37-43. PubMed ID: 7174630
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the serum levels in primary non-agitated depressed out-patients treated with imipramine in combination with placebo, diazepam or dixyrazine.
    Feet PO; Larsen S; Lillevold PE; Liden A; Holm V; Robak OH
    Acta Psychiatr Scand; 1987 Apr; 75(4):435-40. PubMed ID: 2884811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.